High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration

PURPOSE: Intravitreal anti-vascular endothelial growth factor (anti-VEGF) is the first choice of treatment for age-related macular degeneration. However, quite a few eyes treated using conventional dose anti-VEGF (CDAV) have persistent pigment epithelial detachment (PED) on optical coherence tomogra...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Dong Kyu, Kim, Soon Hyun, You, Yong Sung, Kwon, Oh Woong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Ophthalmological Society 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965601/
https://www.ncbi.nlm.nih.gov/pubmed/27478353
http://dx.doi.org/10.3341/kjo.2016.30.4.265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965601/
https://www.ncbi.nlm.nih.gov/pubmed/27478353
http://dx.doi.org/10.3341/kjo.2016.30.4.265

Ejemplares similares